Oral drug delivery system represents one of the frontier area of controlled drug delivery system. Floating drug delivery system belongs to oral controlled drug delivery system group, which is capable of floating in the stomach for prolong period of time. The objective of the present research work is to provide a gastroretentive system for sustained release of therapeutically active agent, cefuroxime axetil in upper part of gastro-intestinal tract in the form of floating tablet. Cefuroxime axetil, an oral prodrug shows a bioavailablity of 30% to 40% when taken on fasting and 5% to 60% whentaken after food. The cefuroxim axetil esterase can hydrolyze cefuroximeaxetil to the nonabsorbable cefuroxim in the gut lumen and is therefore, suspected as a possible cause of incomplete bioavailability. Which suggests an absorption mechanism through the mucosa with limited capacity. Cefuroxime axetil had saturation kinetics that could be overcome by slow release of drug from the formulation, by incorporating cefuroxime axetil in sustained drug delivery system.
INTRODUCTION
FDDS is also called Hydrodynamic Balance System (HBS) system, is an effective technology to prolong the gastric retention time in order to improve the bioavailability of drug. FDDS that float immediately upon contact with gastric fluid present promising approaches for increasing the bioavailability of drugs with absorption windows in the upper intestine.
An attempt has been made to systemically investigate the contribution of several formulation variables on the physico-chemical properties, in vitro drug release and floating properties of floating drug delivery system for absorption window limited drug with short half-life like, Cefuroxime axetil. Cefuroxime axetil (CA) is abroad spectrum ß-lactamase cephalosporin that has well defined pharmacokinetics after intramuscular and intravenous administration in the form of sodium salt. In humans, gastrointestinal absorption of cefuroxime is negligible. Cefuroxime axetil had higher absorption in the proximal region of GI tract and poor absorption, as well as antibiotic associated colitis, when a large amount of drug entered the colon suggest it is an ideal candidate for a gastroretentive drug delivery system that will prolong the gastric residence time of the dosage form, giving prolonged drug release in the upper GI tract, where absorption of cefuroxime is well defined. [1] [2] [3] [4] [5] [6] 
MATERIAL AND METHODS:

Materials:
The drug Cefuroxime axetil was received as a gift sample from Zeel Pharma, Mumbai, India. Hydroxy Propyl Methyl Cellulose-K4M, Eudragit RL-100 and Hydroxy Propyl Cellulose were obtained from Colorcon asia Pvt. Ltd (Goa, India), , Ethyl cellulose, Micro Crystalline Cellulose. Polyvinyl pylorridone, Sodium Bicarbonate, Citric acid, Iso Propyl Alcohol, Magnesium Stearate and lactose were obtained from SD Fine chemicals Mumbai, All the solvent used were of analytical grade.
Methods:
Preformulation studies 7-12 :
(a) Organoleptic properties
The sample of cefuroxime axetil was studied for organoleptic characters such as color, odor and appearance.
(b) Melting point
Melting point was determined by open capillary method using melting point apparatus.
(c) FTIR Spectroscopy
The FTIR spectrum of Cefuroxime axetil was recorded using FTIR spectrophotometer (Shimadzu 8400S) using KBr pellet technique. The peaks are is shown in fig
(d) UV spectroscopy (Determination of λ Max)
Stock solution (100 μg/ml) of cefuroxime axetil was prepared in 0.1N HCL. This solution was appropriately diluted with 0.1N HCL to obtain a concentration of 30 µg/ml. The solution was kept in a fused silica cuvette 10 mm. The UV spectrum was recorded in the range of 200-400 nm on UV Visible Spectrophotometer (Shimadzu 1600) Calibration curve for cefuroxime axetil 100 mg cefuroxime axetil was accurately weighted &transferred to 100ml volumetric flask. It was then dissolved in 0.1NHCL and sonicated for 10 min &diluted to volume with 0.1N hcl to give stock solution containing 1000 mg/ml. This solution was appropriately diluted with 0.1N HCL to obtain a concentration of 5,10,15,20,25,and 30 µg/ml. The above solutions were analyzed by U. V. Spectrophotometer at 280 nm. All the dilutions were made using 0.1N HCL was used as a blank during spectrometric analysis.
(e) Differential scanning calorimetry studies
Thermal analysis was performed using (DSC60 Shimadzu) system with a differential scanning calorimeter equipped with a computerized data station. All samples were weighed and heated at a scanning rate of 10°C/min between 30 and 300°C and 40 ml/min of nitrogen flow. The differential scanning calorimetry analysis gives an idea about the interaction of various materials at different temperature. It also allows us to study the possible degradation pathway of the materials.
(f) Determination of solubility
Cefuroxime Axetil solubility study was carried out using saturation method.
(g) Drug Excipients Interaction
The possibility of any interaction between the drug and the carriers was detected by Fourier Transform Infrared (FTIR) spectroscopy and Differential Scanning Calorimetry (DSC).
Fabrication of Tablets 13-19 :
Each floating tablets containing 250mg cefuroxime axetil were prepared by a conventional wet granulation method, employing sodium bicarbonate, citric acid as gas generating agent and different polymers in each formulation. Cefuroxime Axetil, Lactose and polymers were passed from sieve of # 40 and mixed for 10 min. Gas generating agent was then passed through sieve of # 60 added to the above mixture. Binding solution of polyvinyl pyloridone was Prepared in Isopropyl alcohol. Dry at room temperature and pass from sieve of # 40. Magnesium stearate was passed through sieve of # 60 and added to the above mixture. The whole bulk of granules were then mixed thoroughly for 15 min. The granules were then compressed to form a tablet. 
Evaluation of Granule Properties 20-28 :
The flow properties of granules were characterized in terms of angle of repose, Carr's index and Hausner's ratio.The bulk density and tapped density were determined and from this data Carr's index and Hausner's ratio were calculated.
(a) Bulk density:
Both untapped bulk density, ρ u (often called loose or aerated bulk density) and tapped bulk density, ρ b were determined. A amount of powder blend was introduced in a 10 ml measuring cylinder up to 9 ml volume.Then the weight of powder blend was determined by substracting the weight of empty measuring cylinder from final weight of measuring cylinder. The cylinder was allowed to fall onto a hard surface from a height of 2.5 cm at 2 sec intervals. The tapping was continued till no volume change was noted. ρ u and ρ b were determined by following formulas;
(1)
(2)
(b) Carr's Compressibility Index:
An important measure that can be obtained from bulk density determinations is the percent compressibility C, which is defined as follows (4)
(d) Angle of repose:
The angle of repose of the powder blend was determined by using funnel method. The accurately weighed powder were taken in a funnel. The height of the funnel was adjusted in such a way that the tip of the funnel just touched the apex of the heap of the powder. The diameter of the powder cone was measured and angle of repose was calculated by using the equation Where h and r are the height and radius of the powder cone.
Average values are shown in Table   Table 2 : Standard values of angle of repose (θ).
Evaluation of tablets 20-25 : (a) Tablet thickness and size
Thickness and diameter of tablets were important for uniformity of tablet size. Thickness and diameter was measured using Vernier callipers.
(b) Tablet hardness
The resistance of tablets to shipping or breakage, under conditions of storage, transportation and handling before usage depends on its hardness. The hardness of tablet of each formulation was measured by Monsanto hardness tester. The hardness was measured in terms of kg/cm 2 .
(c) Friability
Friability is the measure of tablet strength. Roche type friabilator was used for testing the friability using the following procedure. Twenty tablets were weighed accurately and placed in the tumbling apparatus that revolves at 25 rpm dropping the tablets through a distance of six inches with each revolution. After 4 min., the tablets were weighed and the percentage loss in tablet weight was determined.
Initial wt. of tablets -Final wt. of tablets % loss  x100 Initial wt. of tablets
(d) Uniformity of weight
Twenty tablets were selected at random and the average weight was calculated. Weight variation was calculated and was compared with I. P. standards.
(e) Drug content
Five tablets were weighed and powdered. The quantity equivalent to 5oo mg of cefuroxime axetil was weighed accurately and taken in 500-ml volumetric flask. 200 milliliters of 0.1N HCl was added, sonicated for 5 min, made up to 500 ml with 0.1 N HCl, and filtered. From above solution further dilution was made and the drug concentration was determined at 278 nm by using UV spectrophotometer. Drug content was calculated by using absorbance at wavelength 280 nm. The results obtained were compared with I. P. standards.
(f) Matrix integrity
Matrix integrity was observed throughout in vitro dissolution studies and the swollen mass of the tablets remain intact or not was checked.
(g)Buoyancy lag time
This test was performed in beaker containing 200 ml pH 1.2 buffer as a testing medium maintained at 37°C. The time required for the tablet to rise to the surface and float was determined as buoyancy lag time.
(h) The duration of Buoyancy time
The time, for which the tablet constantly floats on the surface of the medium, duration of buoyancy, was measured. The duration of buoyancy was determined using a USP dissolution apparatus Type II containing 900 mL of 0.1 N HCL at 50 rpm. The swelling index of tablet was determined in 900 ml Glycin (pH 3) using USP dissolution apparatus Type II at 75 rpm. The medium was maintained at 37±0.5 •C throughout the study. After a selected time intervals, the tablet was withdrawn, blotted to remove excess water and weighed. Swelling characteristics of the tablet was expressed in terms of swelling index where W 0 is the initial weight of tablet, & W t is the weight of tablet at time t.
Flowability
Angle of repose
(j) In vitro dissolution studies
The release rate of cefuroxime axetil from matrix tablets was determined using USP dissolution testing apparatus II (Paddle type). The dissolution test was performed using 900 ml of 0.1N HCL, at 37 ± 0.5°C and 50 rpm. A 5 ml sample solution was withdrawn from the dissolution apparatus for 30 min, 1 hr and there after every hour for 12 hrs. Samples were replaced by its equivalent volume of dissolution medium. The samples were filtered through Whatman filter paper and solutions were analyzed at 280 nm by UV Spectrophotometer (Libindia Disso-2000). Cumulative percentage drug release was calculated.
Drug release kinetics
Dissolution data of above two methods was fitted in Zero order, First order and Higuchi equations.
The mechanism of drug release was determined by using Korsmayer Peppas equation.
Zero-Order Kinetics:
Zero order as cumulative amount of drug released vs time,
C = K 0 t
Where K 0 is the zero-order rate constant expressed in units of concentration/time and t is the time in hours. A graph of concentration vs time would yield a straight line with a slope equal to K 0 and intercept the origin of the axes.
First order kinetics:
First order as log cumulative percentage of drug remaining vs time,
L o g C = L o g C o − k t / 2.303
Where C 0 is the initial concentration of drug, k is the first order constant, and t is the time.
Higuchi Model:
Higuchi's model as cumulative percentage of drug released vs square root of time
Q = K t 1 / 2
Where K is the constant reflecting the design variables of the system and t is the time in hours. Hence, drug release rate is proportional to the reciprocal of the square root of time.
Korsmayer Peppas equations:
To evaluate the mechanism of drug release from Disulfiram implant, data for the first 60% of drug release were plotted in Korsmeyer et al's equation log cumulative percentage of drug released vs log time, and the exponent n was calculated through the slope of the straight line.
M t / M ∞ = K t n
where M t /M ∞ is the fractional solute release, t is the release time, K is a kinetic constant characteristic of the drug/polymer system, and n is an exponent that characterizes the mechanism of release of tracers. For cylindrical matrix tablets, if the exponent n = 0.45, then the drug release mechanism is Fickian diffusion, and if 0.45 < n < 0.89, then it is non-Fickian or anomalous diffusion. An exponent value of 0.89 is indicative of Case-II Transport or typical zero-order release.
RESULTS AND DISCUSSION
PREFORMULATION STUDIES
Characterization of cefuroxime axetil
A. Organoleptic properties
The sample of cefuroxime axetil was found to be a yellowish white to light white crystalline powder. It has characteristic odor and bitter test.
B. Melting point
The melting point of cefuroxime axetil was found to be in the range of 218-225°C
C. FTIR spectroscopy
The FTIR spectrum is shown in Figure 1 and interpretation of FTIR spectra is given in Table 3 .FTIR spectrum of cefuroxime axetil showed all the peaks corresponding to the functional groups present in the structure of cefuroxime axetil. ISSN: 2250-1177 CODEN (USA): JDDTAO 
D. UV spectroscopy (Determination of λ max )
Wavelength of maximum absorbance ( max ) of cefuroxime axetil was found to be 280 nm in 0.1N HCL. The UV spectrum is shown in Figure 2 
Calibration curve for cefuroxime axetil
The calibration curve for cefuroxime axetill in 0.1N HCL is shown in Figure 3 . The graph of absorbance vs. concentration for cefuroxime axetil was found to be linear in the concentration range of 5-30 μg/ml at 280 nm. The r 2 of the calibration curve was found to be 0.997 
CONC.(µg/ml)
ABS.
Linear (ABS.) 
S.N. Peak observed (cm -1 ) Interpretation
E. Differential Scanning Calorimetry study
Differential Scanning Calorimetry studies indicated a sharp endothermic peak at 210°C for pure cefuroxime axetil. 
H. Drug Excipients Interaction
FTIR is called as fingerprint technique and is widely used in identification of drugs and excipients. The FTIR spectra of drug was compared with FTIR spectra of drug and excipients mixture. There was no significant change in the position of this peak in the FTIR spectra of drug and excipients mixture. So it can be concluded that the excipients and drug do not interact with each other.
DSC thermograms of drug and polymer samples showed the peaks at 215.60 o C and 195.30 o C respectively. These are the temperatures corresponding to the melting points of Cefuroxime axetil and polymers respectively. There was no significant change in the position of this peak in the thermograms of drug and excipients mixture. So it can be concluded that the excipients and drug do not interact with each other. 
EVALUATION OF TABLETS (A)Tablet thickness and size
Size of formulations was found to be 9.5 to 11.5 mm.
Thickness was found to be 5.0 to 5.4 mm for all the formulations. Every measurement was made in triplicate.
Table 5: Tablet thickness and size (B)Tablet hardness
Hardness of tablets of each formulation was measured and was found in the range of 3-5 kg/cm 2 . Each sample was analyzed in triplicate.
(C)Friability
Percentage weight loss of the tablets of each formulation was measured and was found to be less than 1% for all the formulations (E)Uniformity of weight Tablets from each batch showed uniformity of weight as per I. P. limits. Average weight of the tablet was found to be from 482 mg to 500 mg for all formulations 
(G)Buoyancy lag time
Increasing the polymer concentration decreased the buoyancy lag time. Carbon dioxide which was liberated by the reaction of the sodium bicarbonate with the acidic environment of the gastric contents is entrapped in the gellified hydrocolloid. This produced an upward motion of the dosage form and maintains its buoyancy.
Buoyancy lag time for all formulations was found to be less than 1 min. 
(H) Buoyancy time
Total floating time of all formulations is shown in Table   Table 8 : Buoyancy Lag Time Table 9 : 
In vitro dissolution studies
Drug release kinetics:
Drug release profiles of the formulations were determined by fitting the dissolution data to zero order, first order and Higuchi equation. The equation for which the highest R 2 was obtained was considered as the best fit release profile. The mechanism of drug release was determined by fitting the drug release data to Korsmeyer's Peppas equation. The detail data treatment is presented in the next section.
Drug Release Kinetics
For all the formulation Korsmeyer's Peppas exponent (n) was found to be greater than 0.5 (>0.5). This indicated that mechanism of drug release controlled from the Cefuroxime Axetil floating tablet was based on diffusion as well as erosion phenomenon. The in vitro release kinetics exhibited a non-Fickian transport model. This kind of diffusion corresponds to a more predictable type of swelling-controlled system. From the results shown in Table 11 , we can conclude that,
The overall order of release data of drug from implant, fitting in different mathematical model is as follows,
F1 BATCH:
Zero order > First order > Korsmeyer Peppas > Higuchi
F2 BATCH:
Zero order > Korsmeyer Peppas > Higuchi > First order
F3 BATCH
F4 BATCH:
F5 BATCH:
F6 BATCH:
F7 BATCH:
Zero order > Korsmeyer Peppas > Higuchi > First order Release rate constant: The release rate constant (k) of Zero order and First order for in vitro drug release of all formulations are given below in table 12   Table 12 : Zero order and first order release rate constants
Release Profile Comparison:
For the present study an attempt was made to prepare the GRDDS of Cefuroxime Axetil with 4 different polymers and their combinations. The study reveals that the drug release from formulations is depend upon the swelling, molecular weight and diffusion ability of polymers. From the observation it is concluded that formulation containing HPMC K4M and HPC i.e F1 & F4 shows the better release rate as it is used alone and having good swelling properties.
The batches F1, F5, F6 and F7 were prepared using polymers HPMC K4M, HPMC K4M: Ethyl Cellulose, HPMC K4M:Eudragit RL100 and HPMC K4M: HPC respectively and Floating tablets were prepared for each batch.
The drug release rate decreased in the rank order;
F7 > F5 > F1> F6
This can probably be attributed to the different diffusion and swelling behavior of the combination of these polymers. With increasing molecular weight, the degree of entanglement of polymer chain increases. Thus, the mobility of the drug molecules in the fully swollen systems decreases. This leads to decreased drug diffusion coefficients and decreased drug release rate with increase molecular weight. It is stated that a faster and greater drug release was expected for reasons with the evolution of gas, the matrix would become more relaxed allowing water penetration and diffusion of drug might be easier.
The drug release from F6 (HPMC K4M: Eudragit RL 100) shows that, as HPMC K4M used in combination with eudragit RL 100, the drug release of formulation is decreases as compare to F1 (HPMC K4M). This is because of the swelling properties of polymers.
From the above observation it is concluded that formulation F7 (HPMC-K: HPC) is the best formulation among all other 6 formulations because it is showing very controlled release of drug from Tablet formulations
Formulations Zero order First order Higuchi equation Korsmeyar's Peppas
Equation of line
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